Blair William & CO Horizon Therapeutics Public LTD CO Transaction History

Blair William & CO

$32 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $19,749 - $23,037	205 Added 6.18%	3,521 $362,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $427,348 - $451,957	-3,982 Reduced 54.56%	3,316 $361,000
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $418,075 - $762,573	-6,701 Reduced 47.87%	7,298 $830,000
Q3 2022 Nov 09, 2022	SELL	$58.92 - $84.67 $159,378 - $229,032	-2,705 Reduced 16.19%	13,999 $866,000
Q2 2022 Aug 10, 2022	SELL	$79.4 - $116.36 $178,888 - $262,159	-2,253 Reduced 11.88%	16,704 $1.33 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $181,395 - $230,491	-2,099 Reduced 9.97%	18,957 $1.99 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $291,146 - $354,214	-2,954 Reduced 12.3%	21,056 $2.27 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $397,143 - $476,908	-4,321 Reduced 15.25%	24,010 $2.63 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $32,167 - $35,778	373 Added 1.33%	28,331 $2.65 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $162,551 - $216,071	-2,263 Reduced 7.49%	27,958 $2.57 Million
Q4 2020 Feb 09, 2021	SELL	$67.0 - $84.39 $20,368 - $25,654	-304 Reduced 1.0%	30,221 $2.21 Million
Q3 2020 Nov 06, 2020	SELL	$55.23 - $79.93 $310,226 - $448,966	-5,617 Reduced 15.54%	30,525 $2.37 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $151,664 - $286,153	-5,022 Reduced 12.2%	36,142 $2.01 Million
Q1 2020 May 11, 2020	SELL	$24.87 - $38.56 $156,954 - $243,352	-6,311 Reduced 13.29%	41,164 $1.22 Million
Q4 2019 Feb 13, 2020	BUY	$25.43 - $36.67 $910,826 - $1.31 Million	35,817 Added 307.23%	47,475 $1.72 Million
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $29,325 - $35,661	-1,275 Reduced 9.86%	11,658 $317,000
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $295,001 - $368,331	12,933 New	12,933 $311,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account